Eli Lilly and Company Profile Avatar - Palmy Investing

Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…
Drug Manufacturers - General
US, Indianapolis [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
80.55 81.08 79.13 78.78 78.76 74.85 74.76 73.35 73.46 78.22 78.85 77.66 74.18 76.77 80.73
Profit Margin
19.82 21.97 17.90 18.09 20.27 12.19 12.07 12.90 -0.89 15.04 20.78 25.24 19.71 21.88 15.36
Operating Margin
29.17 29.35 22.76 20.94 23.24 13.56 13.47 16.30 9.38 28.78 22.29 24.69 22.45 24.97 30.26
EPS Growth
308.47 16.24 -14.85 -5.90 17.98 -48.50 1.79 14.10 -107.34 1,752.63 58.60 36.95 -9.82 12.68 -16.02
Return on Assets (ROA)
15.76 16.35 12.92 11.89 13.29 6.43 6.77 7.05 -0.45 7.36 11.81 13.28 11.44 12.62 8.19
Return on Equity (ROE)
45.45 40.82 32.11 27.69 26.57 15.55 16.53 19.54 -1.76 32.88 177.91 109.79 62.16 58.64 48.65
Return on Invested Capital (ROIC)
31.80 27.20 21.89 17.63 18.70 9.04 10.30 11.54 -0.79 26.32 23.80 23.34 22.29 24.32 22.93
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
24.26 22.34 20.76 16.08 14.79 21.67 22.43 26.56 30.34 23.46 40.23 35.59 34.60 32.81 39.41
Debt/Equity
69.95 55.77 51.60 37.46 29.57 52.41 54.76 73.57 117.73 104.78 606.23 294.16 188.04 152.48 234.18
Debt/EBITDA
28.40 11.45 14.83 33.55 26.44 104.68 95.94 133.60 92.14 30.88 203.89 169.32 149.51 150.23 179.89
Debt/Capitalization
41.16 35.80 34.04 27.25 22.82 34.39 35.38 42.39 54.07 51.17 85.84 74.63 65.28 60.39 70.08
Interest Debt per Share USD
6.30 6.43 6.44 5.13 4.97 7.67 7.67 9.91 13.19 10.29 17.40 18.68 18.99 18.38 28.37
Debt Growth
-36.32 3.97 0.87 -20.83 -5.76 54.55 -0.97 29.16 32.43 -24.54 53.46 5.01 1.74 -3.83 55.34
Liquidity
Current Ratio
190.11 208.97 159.54 155.42 146.97 108.68 152.79 137.45 132.10 172.86 116.43 139.90 122.59 105.23 94.26
Quick Ratio
126.82 153.28 124.68 114.10 105.65 76.99 103.57 98.35 91.47 110.92 67.77 85.01 79.96 62.85 52.26
Cash Ratio
67.95 84.39 66.31 47.90 42.96 34.54 44.55 41.71 44.97 61.58 19.85 29.30 25.37 12.06 10.33
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
149.02 173.42 220.36 181.42 167.58 180.02 146.18 158.76 136.16 151.12 147.97 137.76 188.18 153.83 113.91
Receivables Turnover
569.86 554.97 573.08 581.32 574.55 516.02 490.19 445.25 434.63 372.06 402.77 354.16 348.44 333.47 301.02
Payables Turnover
438.69 407.22 450.40 403.64 438.50 437.24 376.42 419.10 430.30 387.85 335.96 341.28 437.74 343.41 253.04
Asset Turnover
79.52 74.44 72.15 65.71 65.57 52.76 56.11 54.69 50.85 48.95 56.81 52.62 58.02 57.67 53.31
Coverage
Interest Coverage
2,437.81 3,650.78 2,972.31 2,662.65 3,354.40 1,787.50 1,668.36 1,867.60 953.33 2,273.72 1,241.71 1,684.65 1,870.84 2,149.37 3,306.24
Asset Coverage
200 200 300 400 400 300 200 200 200 300 100 100 100 100 100
Cash Flow Coverage (CFGR)
65.08 98.99 103.54 95.91 110.02 54.21 34.75 47.07 41.15 53.64 30.60 39.17 43.00 43.63 16.81
EBITDA Coverage
2,900 4,300 3,800 2,500 3,200 2,600 2,700 2,300 3,400 3,500 1,600 2,100 2,500 2,800 3,900
Dividend Coverage
-200 -200 -100 -100 -200 -100 -100 -100 - - -100 -100 -200 -100 -100 -100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
5.49 5.59 4.71 3.98 3.85 2.85 2.38 2.77 2.47 1.94 1.97 1.75 1.23 1.07 0.78
Earnings Yield
11.04 13.08 9.39 7.45 8.50 3.24 2.69 3.52 -0.23 2.72 3.79 4.04 2.23 1.89 1.00
Price/Earnings (P/E)
906.06 764.31 1,064.81 1,342.81 1,176.67 3,087.83 3,715.20 2,843.36 -43,534.47 3,679.70 2,638.46 2,474.21 4,488.26 5,282.65 10,013.23
Price/Book (P/B)
411.83 311.96 341.87 371.83 312.65 480.15 614.06 555.69 766.50 1,210.01 4,694.05 2,716.34 2,790.02 3,097.63 4,871.32
Price/Sales (P/S)
179.62 167.91 190.62 242.89 238.50 376.31 448.31 366.79 388.50 553.33 548.26 624.48 884.66 1,155.83 1,537.72
Price/Cash Flow (P/CF)
904.66 565.09 639.91 1,034.95 961.20 1,690.24 3,226.95 1,604.61 1,582.27 2,152.74 2,530.06 2,357.76 3,450.37 4,656.58 12,375.50